RCT | Effectiveness of Mycophenolate Mofetil among patients with progressive IgA nephropathy
10 Feb, 2023 | 13:52h | UTC
Commentary on Twitter
RCT: For patients with IgA nephropathy at high risk of disease progression, addition of mycophenolate to optimized supportive care reduced risk of kidney function loss, vs supportive care alone. https://t.co/xjyD3hseG7 pic.twitter.com/BlQiXkyBLn
— JAMA Network Open (@JAMANetworkOpen) February 6, 2023